Ontology highlight
ABSTRACT: Methods
In May 2022, EULAR and PReS endorsed a proposal for a joint task force (TF) to develop recommendations for the diagnosis and management of sJIA and AOSD. The TF agreed during a first meeting to address four topics: similarity between sJIA and AOSD, diagnostic biomarkers, therapeutic targets and strategies and complications including macrophage activation syndrome (MAS). Systematic literature reviews were conducted accordingly.Results
The TF based their recommendations on four overarching principles, highlighting notably that sJIA and AOSD are one disease, to be designated by one name
SUBMITTER: Fautrel B
PROVIDER: S-EPMC11672000 | biostudies-literature | 2024 Nov
REPOSITORIES: biostudies-literature